Post-Authorisation Safety Study of Esbriet® (Pirfenidone): A Prospective Observational Registry to Evaluate Long-Term Safety in Real-World Setting (PASSPORT)

21/02/2012
31/03/2024
EU PAS number:
EUPAS2165
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol WB29908 (PIPF-025)_Redacted_final

English (292.68 KB - PDF) View document
Study results
Study results

WB29908 CSR Synopsis_Redacted

English (13.79 KB - PDF) View document
Study report
Other information